Necrotising Candida oesophagitis after thoracic radiotherapy: Significance of oesophageal wall oedema on CT

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Saito, Hirotake ^a   Sueyama, Hiroo ^b   Fukuda, Takanori ^b   Ota, Kyuma ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata Prefectural Central Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE;

AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DYSPHAGIA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS CANDIDIASIS; ESOPHAGUS MUCOSA; FOLLOW UP; HUMAN; JAPANESE (PEOPLE); MALE; NECROTISING CANDIDA ESOPHAGITIS; NECROTIZING ESOPHAGITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; CANDIDA; CANDIDIASIS; COMPLICATION; DEGLUTITION DISORDERS; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FATALITY; ISOLATION AND PURIFICATION; PATHOLOGY; RADIOGRAPHY; TUMOR RECURRENCE;

AGED; CANDIDA; CANDIDIASIS; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGITIS; FATAL OUTCOME; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL;

EID: 84939484751     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2015-210477     Document Type: Article

References (15)

1. Dorocka-Bobkowska B, Budtz-Jörgensen E, Włoch S. Non-insulin-dependent diabetes mellitus as a risk factor for denture stomatitis. J Oral Pathol Med 1996;25:411-15.
2. Dahiya MC, Redding SW, Dahiya RS, et al. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;57:79-83.
3. Hirota S, Tsujino K, Hishikawa Y, et al. Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol 2001;58:273-8.
4. Wilcox CM, Schwartz DA. Endoscopic-pathologic correlates of Candida esophagitis in acquired immunodeficiency syndrome. Dig Dis Sci 1996;41:1337-45.
5. Graman PS. Esophagitis. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases: 2-volume set. 8th edn. Saunders, 2014:1248-52.
6. Wilcox CM, Alexander LN, Clark WS, et al. Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms. Gastroenterology 1996;110:1803-9.
7. Gaissert HA, Breuer CK, Weissburg A, et al. Surgical management of necrotizing Candida esophagitis. Ann Thorac Surg 1999;67:231-3.
8. Jones JM, Glass NR, Belzer FO. Fatal Candida esophagitis in two diabetics after renal transplantation. Arch Surg 1982;117:499-501.
9. Baumann M, Grégoire V. Modified fractionation. In: Joiner MC, van der Kogel A, eds. Basic clinical radiobiology. 4th edn. CRC Press, 2009:135-48.
10. Jones JM. Necrotizing Candida esophagitis. Failure of symptoms and roentgenographic findings to reflect severity. JAMA 1980;244:2190-1.
11. Tran HA, Vincent JM, Slavin MA, et al. Esophageal perforation secondary to angio-invasive Candida glabrata following hemopoietic stem cell transplantation. Clin Microbiol Infect 2003;9:1215-18.
12. Miller TE, Findon G. Experimental candidosis: paw oedema in the analysis of a local infection. J Med Microbiol 1985;20:283-90.
13. Klotz SA. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin Infect Dis 1992;14:340-7.
14. Macari M, Balthazar EJ. CT of bowel wall thickening: significance and pitfalls of interpretation. AJR Am J Roentgenol 2001;176:1105-16.
15. Nicolatou-Galitis O, Velegraki A, Sotiropoulou-Lontou A, et al. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer 2006;14:44-51.